Author:
Drescher Stefanie K.,Jiao Yuanyuan,Chen Mong-Jen,Kurumaddali Abhinav,Shao Jie,Amini Elham,Hochhaus Günther,Bulitta Jürgen B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference29 articles.
1. Hochhaus G, Davis-Cutting C, Oliver M, Lee SL, Lyapustina S. Current Scientific and Regulatory Approaches for Development of Orally Inhaled and Nasal Drug Products: Overview of the IPAC-RS/University of Florida Orlando Inhalation Conference. AAPS J. 2015;17:1305–11.
2. Lee SL. US regulatory considerations for generic dry powder inhalers. Respiratory drug delivery 2012. Volume 1. In: Dalby RN, Byron PR, Peart J, Suman JD, Young PM, Traini D, editors. River Grove: DHI Publishing; 2012. p. 317–24.
3. O’Connor D, Adams WP, Chen M-L, Daley-Yates P, Davis J, Derendorf H, et al. Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: Workshop summary report. J Aerosol Med Pulm Drug Deliv. 2011;24:119–35.
4. Adams WP, Ahrens RC, Chen M-L, Christopher D, Chowdhury BA, Conner DP, et al. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report. J Aerosol Med Pulm Drug Deliv [Internet]. 2010;23:1–29. https://doi.org/10.1089/jamp.2009.0803.
5. FYs 2013–2017 Regulatory Science Report: Locally-Acting Orally Inhaled and Nasal Drug Products [Internet]. Available from:
https://www.fda.gov/drugs/generic-drugs/fys-2013-2017-regulatory-science-report-locally-acting-orally-inhaled-and-nasal-drug-products. Accessed 23 Mar 2023.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献